|
Index of reports
> Cases resulting in life threatening events (43)
> Cases with Dyspnoea (8)
Below is the selection of adverse event reports related to Oxycontin (Oxycodone) that includes cases resulting in life threatening events where reactions include dyspnoea.
Adverse event in 61 year old male receiving Oxycontin (Oxycodone)
Reported by a individual with unspecified qualification from Japan on 2007-10-09
Patient: 61 year old male, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Pyrexia, Hepatitis, Liver Disorder, Chest X-RAY Abnormal, Interstitial Lung Disease, Gamma-Glutamyltransferase Increased, Malignant Pleural Effusion, Blood Alkaline Phosphatase Increased, Dyspnoea, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Localised Oedema, Pancytopenia, Lymphangiosis Carcinomatosa, Respiratory Distress, Computerised Tomogram Abnormal, Aspartate Aminotransferase Increased, Anorexia
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Zometa
Dosage: 4 mg, unk
Indication: Metastases TO Bone
Start date: 2006-11-14
End date: 2007-01-09
Oxycontin
Dosage: 45 mg/d
Administration route: Oral
Indication: Cancer Pain
Start date: 2006-11-15
Relifen
Dosage: 800 mg/d
Administration route: Oral
Indication: Cancer Pain
Start date: 2006-11-14
End date: 2007-02-01
CPT-11
Dosage: 100 mg/d
Indication: Metastases TO Bone
Start date: 2006-11-24
End date: 2006-11-24
CPT-11
Dosage: 50 mg/d
Start date: 2006-12-08
End date: 2006-12-08
Cddp + Etoposide+ctx+mtx+5-Fu+adr+vcr
Dosage: 50 mg/d
Indication: Metastases TO Bone
Start date: 2006-11-24
End date: 2006-12-08
TS 1
Dosage: 100 mg/d
Administration route: Oral
Indication: Metastases TO Bone
Start date: 2006-04-05
End date: 2006-10-31
Krestin
Dosage: 3 g/d
Administration route: Oral
Indication: Metastases TO Bone
Start date: 2006-07-26
End date: 2006-10-31
DAI-Kenchu-TO
Dosage: 2.5 g/d
Administration route: Oral
Indication: Constipation
Start date: 2006-11-28
End date: 2006-12-20
Other drugs received by patient: Camptosar; Cisplatin; Mucosta; Novamin; Primperan; Maglax
Adverse event in 61 year old male receiving Oxycontin (Oxycodone)
Reported by a individual with unspecified qualification from Japan on 2007-10-02
Patient: 61 year old male, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Pyrexia, Hepatitis, Liver Disorder, Gamma-Glutamyltransferase Increased, Interstitial Lung Disease, Malignant Pleural Effusion, Blood Alkaline Phosphatase Increased, Dyspnoea, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Pancytopenia, Localised Oedema, Lymphangiosis Carcinomatosa, Computerised Tomogram Abnormal, Anorexia, Aspartate Aminotransferase Increased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Zometa
Dosage: 4 mg, unk
Indication: Metastases TO Bone
Start date: 2006-11-14
End date: 2007-01-09
Oxycontin
Dosage: 45 mg/d
Administration route: Oral
Indication: Cancer Pain
Start date: 2006-11-15
Relifen
Dosage: 800 mg/d
Administration route: Oral
Indication: Cancer Pain
Start date: 2006-11-14
End date: 2007-02-01
CPT-11
Dosage: 100 mg/d
Indication: Metastases TO Bone
Start date: 2006-11-24
End date: 2006-11-24
CPT-11
Dosage: 50 mg/d
Start date: 2006-12-08
End date: 2006-12-08
Cddp + Etoposide+ctx+mtx+5-Fu+adr+vcr
Dosage: 50 mg/d
Indication: Metastases TO Bone
Start date: 2006-11-24
End date: 2006-12-08
TS 1
Dosage: 100 mg/d
Administration route: Oral
Indication: Metastases TO Bone
Start date: 2006-04-05
End date: 2006-10-31
Krestin
Dosage: 3 g/d
Administration route: Oral
Indication: Metastases TO Bone
Start date: 2006-07-26
End date: 2006-10-31
DAI-Kenchu-TO
Dosage: 2.5 g/d
Administration route: Oral
Indication: Constipation
Start date: 2006-11-28
End date: 2006-12-20
Other drugs received by patient: Camptosar; Cisplatin; Mucosta; Novamin; Primperan; Maglax
Adverse event in 61 year old male receiving Oxycontin (Oxycodone)
Reported by a physician from Japan on 2007-05-25
Patient: 61 year old male, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Pyrexia, Hepatitis, Liver Disorder, Gamma-Glutamyltransferase Increased, Interstitial Lung Disease, Malignant Pleural Effusion, Blood Alkaline Phosphatase Increased, Dyspnoea, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Pancytopenia, Localised Oedema, Lymphangiosis Carcinomatosa, Computerised Tomogram Abnormal, Anorexia, Aspartate Aminotransferase Increased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Zometa
Dosage: 4 mg, unk
Indication: Metastases TO Bone
Start date: 2006-11-14
End date: 2007-01-09
Oxycontin
Dosage: 45 mg/d
Administration route: Oral
Indication: Cancer Pain
Start date: 2006-11-15
Relifen
Dosage: 800 mg/d
Administration route: Oral
Indication: Cancer Pain
Start date: 2006-11-14
End date: 2007-02-01
CPT-11
Dosage: 100 mg/d
Indication: Metastases TO Bone
Start date: 2006-11-24
End date: 2006-11-24
CPT-11
Dosage: 50 mg/d
Start date: 2006-12-08
End date: 2006-12-08
Cddp + Etoposide+ctx+mtx+5-Fu+adr+vcr
Dosage: 50 mg/d
Indication: Metastases TO Bone
Start date: 2006-11-24
End date: 2006-12-08
TS 1
Dosage: 100 mg/d
Administration route: Oral
Indication: Metastases TO Bone
Start date: 2006-04-05
End date: 2006-10-31
Krestin
Dosage: 3 g/d
Administration route: Oral
Indication: Metastases TO Bone
Start date: 2006-07-26
End date: 2006-10-31
DAI-Kenchu-TO
Dosage: 2.5 g/d
Administration route: Oral
Indication: Constipation
Start date: 2006-11-28
End date: 2006-12-20
Other drugs received by patient: Camptosar; Cisplatin; Mucosta; Novamin; Primperan INJ; Maglax
Adverse event in male receiving Oxycontin (Oxycodone)
Reported by a individual with unspecified qualification on 2007-04-27
Patient: male
Adverse reactions / side effects: Multi-Organ Failure, Dyspnoea, Coma, Myocardial Infarction, Chronic Obstructive Pulmonary Disease, Drug Dependence
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Oxycontin (Oxycodone)
Adverse event in 61 year old male receiving Oxycontin (Oxycodone)
Reported by a physician from Japan on 2007-03-30
Patient: 61 year old male, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Dyspnoea, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Localised Oedema, Pancytopenia, Pyrexia, Hepatitis, Computerised Tomogram Abnormal, Liver Disorder, Gamma-Glutamyltransferase Increased, Interstitial Lung Disease, Malignant Pleural Effusion, Anorexia, Aspartate Aminotransferase Increased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Zometa
Dosage: 4 mg, unk
Indication: Metastases TO Bone
Start date: 2006-11-14
End date: 2007-01-09
Oxycontin
Dosage: 45 mg/d
Administration route: Oral
Indication: Cancer Pain
Start date: 2006-11-15
Relifen
Dosage: 800 mg/d
Administration route: Oral
Indication: Cancer Pain
Start date: 2006-11-14
End date: 2007-02-01
CPT-11
Dosage: 100 mg/d
Indication: Metastases TO Bone
Start date: 2006-11-24
End date: 2006-11-24
CPT-11
Dosage: 50 mg/d
Start date: 2006-12-08
End date: 2006-12-08
Cddp + Etoposide+ctx+mtx+5-Fu+adr+vcr
Dosage: 50 mg/d
Indication: Metastases TO Bone
Start date: 2006-11-24
End date: 2006-12-08
TS 1
Dosage: 100 mg/d
Administration route: Oral
Indication: Metastases TO Bone
Start date: 2006-04-05
End date: 2006-10-31
Krestin
Dosage: 3 g/d
Administration route: Oral
Indication: Metastases TO Bone
Start date: 2006-07-26
End date: 2006-10-31
DAI-Kenchu-TO
Dosage: 2.5 g/d
Administration route: Oral
Indication: Constipation
Start date: 2006-11-28
End date: 2006-12-20
Other drugs received by patient: Camptosar; Cisplatin; Mucosta; Novamin; Primperan INJ; Maglax
Adverse event in 61 year old male receiving Oxycontin (Oxycodone)
Reported by a physician from Japan on 2007-03-15
Patient: 61 year old male, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Dyspnoea, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Localised Oedema, Pancytopenia, Pyrexia, Hepatitis, Computerised Tomogram Abnormal, Liver Disorder, Gamma-Glutamyltransferase Increased, Interstitial Lung Disease, Malignant Pleural Effusion, Anorexia, Aspartate Aminotransferase Increased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Zometa
Dosage: 4 mg, unk
Indication: Metastases TO Bone
Start date: 2006-11-14
End date: 2007-01-09
Oxycontin
Dosage: 45 mg/d
Administration route: Oral
Indication: Cancer Pain
Start date: 2006-11-15
Relifen
Dosage: 800 mg/d
Administration route: Oral
Indication: Cancer Pain
Start date: 2006-11-14
End date: 2007-02-01
CPT-11
Dosage: 100 mg/d
Indication: Metastases TO Bone
Start date: 2006-11-24
End date: 2006-11-24
CPT-11
Dosage: 50 mg/d
Start date: 2006-12-08
End date: 2006-12-08
Cddp + Etoposide+ctx+mtx+5-Fu+adr+vcr
Dosage: 50 mg/d
Indication: Metastases TO Bone
Start date: 2006-11-24
End date: 2006-12-08
TS 1
Dosage: 100 mg/d
Administration route: Oral
Indication: Metastases TO Bone
Start date: 2006-04-05
End date: 2006-10-31
Krestin
Dosage: 3 g/d
Administration route: Oral
Indication: Metastases TO Bone
Start date: 2006-07-26
End date: 2006-10-31
DAI-Kenchu-TO
Dosage: 2.5 g/d
Administration route: Oral
Indication: Constipation
Start date: 2006-11-28
End date: 2006-12-20
Other drugs received by patient: Camptosar; Cisplatin; Mucosta; Novamin; Primperan INJ; Maglax
Adverse event in 61 year old male receiving Oxycontin (Oxycodone)
Reported by a physician from Japan on 2007-02-28
Patient: 61 year old male, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Dyspnoea, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Localised Oedema, Pancytopenia, Pyrexia, Computerised Tomogram Abnormal, Hepatitis, Liver Disorder, Gamma-Glutamyltransferase Increased, Interstitial Lung Disease, Aspartate Aminotransferase Increased, Anorexia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zometa
Dosage: 4 mg, unk
Indication: Metastases TO Bone
Start date: 2006-11-14
End date: 2007-01-09
Oxycontin
Dosage: 45 mg/d
Administration route: Oral
Indication: Cancer Pain
Start date: 2006-11-15
Relifen
Dosage: 800 mg/d
Administration route: Oral
Indication: Cancer Pain
Start date: 2006-11-14
End date: 2007-02-01
CPT-11
Dosage: 100 mg/d
Indication: Metastases TO Bone
Start date: 2006-11-24
End date: 2006-11-24
CPT-11
Dosage: 50 mg/d
Start date: 2006-12-08
End date: 2006-12-08
Cddp + Etoposide+ctx+mtx+5-Fu+adr+vcr
Dosage: 50 mg/d
Indication: Metastases TO Bone
Start date: 2006-11-24
End date: 2006-12-08
TS 1
Dosage: 100 mg/d
Administration route: Oral
Indication: Metastases TO Bone
Start date: 2006-04-05
End date: 2006-10-31
Krestin
Dosage: 3 g/d
Administration route: Oral
Indication: Metastases TO Bone
Start date: 2006-07-26
End date: 2006-10-31
DAI-Kenchu-TO
Dosage: 2.5 g/d
Administration route: Oral
Indication: Constipation
Start date: 2006-11-28
End date: 2006-12-20
Other drugs received by patient: Camptosar; Cisplatin; Mucosta; Novamin; Primperan; Maglax
Adverse event in male receiving Oxycontin (Oxycodone)
Reported by a individual with unspecified qualification from United States on 2007-01-26
Patient: male
Adverse reactions / side effects: Dyspnoea, Myocardial Infarction, Cardiac Arrest
Adverse event resulted in: life threatening event
Suspect drug(s):
Oxycontin (Oxycodone)
|
